MDSCs release IL-10 to downregulate IL-12 secretion by macrophages while macrophages in turn induce MDSCs to increase IL-10 which decreases IL-6 and TNF-α in macrophages and therefore skewing the immunity towards tumor promoting type 2 response [78]. This evidence concerns the gene IL10 and neoplasm.